Targeted pyrrolobenzodiazapine conjugates

Details for Australian Patent Application No. 2011239522 (hide)

Owner Seattle Genetics, Inc. Spirogen Developments SARL

Inventors Howard, Philip Wilson; Jeffrey, Scott; Burke, Patrick; Senter, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2011239522

PCT Pub. Number WO2011/130613

Priority 61/324,623 15.04.10 US

Filing date 15 April 2011

Wipo publication date 20 October 2011

International Classifications

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/130613 Priority application(s): WO2011/130613

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239525-Pyrrolobenzodiazepines used to treat proliferative diseases

2011239512-Anti-VLA-4 antibodies